SOBR Safe, Inc.

Company Improves Balance Sheet With Additional Capital to Support Proposed Merger DENVER, CO / ACCESS Newswire / July 17, 2026 / SOBR Safe, Inc. (Nasdaq:SOBR) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, today announced the closing of its previously announced exercise of certain outstanding warrants to purchase up to an aggregate of 2,360,648 shares originally issued in December 2025, having an exercise price of $1.30 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No. 333-292709). H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. In consideration for the immediate exercise of the warrants for cash, the Company issued new unregistered Series E warrants to purchase up to 2,580,648 shares of common stock and new unregistered Series F warrants to purchase up to 2,140,648 shares of common stock. The Series E new warrants have an exercise price of $1.30 per share, are exercisable immediately and will expire five years after the effective date of the Resale Registration Statement (as defined below). The Series F new warrants have an exercise price of $1.30 per share, are exercisable immediately and will expire twenty-four months after the effective date of the Resale Registration Statement (as defined below). The aggregate gross proceeds to the Company from the offering were approximately $3.1 million, before deducting placement agent fees and other offering expenses. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes. The new warrants described above were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the "Act") and, along with the shares of common stock issuable upon their exercise, have not been registered under the Act, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission ("SEC") or an applicable exemption from such registration requirements. The Company has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new warrants (the "Resale Registration Statement"). This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About SOBRsafe™ Through next-generation alcohol detection technology, we enable trust and empower recovery ... with a human touch. SOBRsafe's advanced transdermal (touch-based) technology detects and reports in real-time the presence of alcohol as emitted through a user's skin - no breath, blood, or urine samples are required. With a powerful backend data platform, SOBRsafe provides passive, dignified screening and monitoring solutions for the behavioral health, family law and consumer markets, and for licensing and integration. To learn more, visit www.sobrsafe.com. Safe Harbor Statement Our prospects here at SOBRsafe are subject to uncertainties and risks. This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements regarding the intended use of net proceeds from the offering, and the Company intends that such forward-looking statements

The Company Strengthens Balance Sheet to Support Proposed Merger, Takes Strides to Regaining Nasdaq Listing Compliance DENVER, CO / ACCESS Newswire / July 15, 2026 / SOBR Safe, Inc. (Nasdaq:SOBR) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,360,648 shares originally issued in December 2025, having an exercise price of $1.30 per share, at a reduced exercise price of $1.05 per share. The shares of common stock issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No. 333-292709). H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. In consideration for the immediate exercise of the warrants for cash and the payment of an additional $0.125 per new unregistered warrant (additional $590,162 in the aggregate, which are included in the gross proceeds to the Company), the Company will issue new unregistered Series E warrants to purchase up to 2,360,648 shares of common stock and new unregistered Series F warrants to purchase up to 2,360,648 shares of common stock. The Series E new warrants will have an exercise price of $1.30 per share, will be exercisable immediately and will expire five years after the effective date of the Resale Registration Statement (as defined below). The Series F new warrants will have an exercise price of $1.30 per share, will be exercisable immediately and will expire twenty-four months after the effective date of the Resale Registration Statement (as defined below). The aggregate gross proceeds to the Company from the offering are expected to be approximately $3.1 million, before deducting placement agent fees and other offering expenses. The offering is expected to close on or about July 16, 2026, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes. The new warrants described above were offered in a private placement pursuant to an applicable exemption from the registration requirements of the Securities Act of 1933, as amended (the "Act") and, along with the shares of common stock issuable upon their exercise, have not been registered under the Act, and may not be offered or sold in the United States absent registration with the Securities and Exchange Commission ("SEC") or an applicable exemption from such registration requirements. The Company has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issuable upon exercise of the new warrants (the "Resale Registration Statement"). This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About SOBRsafe™ Through next-generation alcohol detection technology, we enable trust and empower recovery ... with a human touch. SOBRsafe's advanced transdermal (touch-based) technology detects and reports in real-time the presence of alcohol as emitted through a user's skin - no breath, blood, or urine samples are required. With a powerful backend data platform, SOBRsafe provides passive, dignified screening and monitoring solutions for the behavioral health, family law and consumer markets, and for licensing and integration. To learn more, visit www.sobrsafe.com. Safe Harbo

Proposed Business Combination with Clean World Ventures, Inc., a Zero‑Carbon Green Energy Technology Manufacturing Company, to Support Power-Intensive Applications, Including AI Data Centers SOBRsafe to Explore Strategic Alternatives for Its Alcohol Monitoring and Detection Technology Business DENVER, CO / ACCESS Newswire / April 30, 2026 / SOBR Safe, Inc. (Nasdaq:SOBR) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, and Clean World Ventures, Inc. ("CWV"), have entered into a Definitive Agreement for a proposed business combination (the "Proposed Transaction") of SOBRsafe's alcohol monitoring and detection technology business, SOBRsafe, with CWV, which, once closed will go forward as and operate under the name Clean World Ventures, Inc. Clean World Ventures, Inc. (CWV), formerly Clean Water Ventures, Inc., is a zero‑carbon Green Energy technology manufacturing company backed by real-time AI manufacturing and Cybersecure SCADA. CWV designs and manufactures advanced distributed green hydrogen and clean electricity generation systems. CWV's technology enables onsite, independent distributed power production to support AI/data centers, critical materials mining, heavy industries, industrial manufacturing operations, transportation and other commercial applications. CWV is currently engaged in active discussions with hyperscale data center operators seeking scalable, on-site clean energy solutions to meet the growing demands of AI-driven workloads. The Proposed Transaction is intended to establish differentiated proprietary energy systems that are highly configurable, fully self‑sustaining, and entirely carbon‑free. By utilizing wastewater and scrap aluminum as feedstock, the company eliminates any carbon legacy while transforming waste into clean, reliable energy. These systems are designed to be deployed directly where energy is consumed, significantly reducing dependence on centralized power grids and increasing energy resilience. Upon closing of the Proposed Transaction, CWV would own approximately 98% of the public combined company. The intent is for the SOBRsafe and CWV businesses to continue to operate independently upon consummation of the Proposed Transaction and SOBRsafe plans to continue evaluating opportunities to monetize the value of its alcohol monitoring and detection technology business. "Rising global demand for 24/7 clean, reliable energy, driven in large part by the rapid expansion of data centers and AI-driven workloads, continues to outpace the capacity and flexibility of traditional power infrastructure, creating an urgent need for scalable, on-site, zero-carbon solutions," said Clean World Ventures CEO Roy DiBenerdini. "The Proposed Transaction with SOBRsafe represents a compelling opportunity to strategically align capital, innovation, and shared purpose. We believe this combination positions us to expand our market reach, support a growing base of hyperscale and global enterprise customers, and accelerate the transformation of the global energy industry through our distributed clean energy appliances." "Clean World Ventures is intended to advance zero-emission clean electricity and hydrogen technology to create clean distributed energy, and sustainable infrastructure," said SOBRsafe CEO David Gandini. "As demand intensifies for energy solutions that address decarbonization, the transition to a greener future will require innovative purpose-driven organizations like Clean World Ventures to lead this next evolution of the global energy landscape and drive shareholder value. We believe this business combination is consistent with SOBR's purpose-driven mission, and will be additive in maximizing and growing market value for SOBR shareholders." Clean World Ventures is positioned t

When someone drinks after deciding to go alcohol-free, it can feel frustrating and even embarrassing. Those feelings often prompt people to withdraw from their support network when they need it most.More

When drinking alcohol has been a big part of your life and you stop, it’s a lifestyle change that can change relationships, too. Here are some helpful tips for navigating relationships on the journey to sobriety.More

If you’re ready to stop drinking but aren’t sure which type of support will help you succeed, keep this in mind: there isn’t just one “right” path.More

DENVER, CO / ACCESS Newswire / December 29, 2025 / SOBR Safe, Inc. (NASDAQ:SOBR) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, today announced the closing of its previously announced private placement priced at-the-market under Nasdaq rules for the issuance and sale of 1,290,324 shares of its common stock (or pre-funded warrants in lieu thereof), Series C warrants to purchase up to an aggregate of 1,290,324 shares of common stock and Series D warrants to purchase up to an aggregate of 1,290,324 shares of common stock, at a purchase price of $1.55 per share (or pre-funded warrant in lieu thereof) and associated warrants. The warrants have an exercise price of $1.30 per share and are exercisable immediately upon issuance. The Series C warrants will expire five years after the effective date of the Resale Registration Statement (as defined below) and the Series D warrants will expire twenty-four months after the effective date of the Resale Registration Statement. H.C. Wainwright & Co. acted as the exclusive placement agent for the offering. Aegis Capital Corp. received a cash tail fee. The aggregate gross proceeds to the Company from the offering were approximately $2.0 million, before deducting placement agent fees and other offering expenses. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes. The securities described above were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Act") and Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants sold in the offering, have not been registered under the Act or applicable state securities laws. Accordingly, such securities may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. Pursuant to a registration rights agreement, the Company has agreed to file one or more registration statements with the SEC covering the resale of the unregistered securities to be issued in the offering (the "Resale Registration Statement"). This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About SOBRsafe™Through next-generation alcohol detection technology, we enable trust and empower recovery ... with a human touch. SOBRsafe's advanced transdermal (touch-based) technology detects and reports in real-time the presence of alcohol as emitted through a user's skin - no breath, blood, or urine samples are required. With a powerful backend data platform, SOBRsafe provides passive, dignified screening and monitoring solutions for the behavioral health, family law and consumer markets, and for licensing and integration. To learn more, visit www.sobrsafe.com. Safe Harbor StatementOur prospects here at SOBRsafe are subject to uncertainties and risks. This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934, including statements regarding the intended use of net proceeds from the offering, and the Company intends that such forward-looking statements be subject to the safe harbor provided by the foregoing. These forward-looking statements are based largely on the expectations or forecasts of future events, can be affected by inaccurate a

DENVER, COLORADO / ACCESS Newswire / December 24, 2025 / SOBR Safe, Inc. (Nasdaq:SOBR) ("SOBRsafe" or the "Company"), the leader in next-generation alcohol monitoring and detection technology, today announced that it has entered into definitive agreements for the issuance and sale of 1,290,324 shares of its common stock (or pre-funded warrants in lieu thereof), Series C warrants to purchase up to an aggregate of 1,290,324 shares of common stock and Series D warrants to purchase up to an aggregate of 1,290,324 shares of common stock, at a purchase price of $1.55 per share (or pre-funded warrant in lieu thereof) and associated warrants in a private placement priced at-the-market under Nasdaq rules. The warrants will have an exercise price of $1.30 per share and will be exercisable immediately upon issuance. The Series C warrants will expire five years after the effective date of the Resale Registration Statement (as defined below) and the Series D warrants will expire twenty-four months after the effective date of the Resale Registration Statement. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The aggregate gross proceeds to the Company from the offering are expected to be approximately $2.0 million, before deducting placement agent fees and other offering expenses. The offering is expected to close on or about December 29, 2025, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds from the offering for working capital and general corporate purposes. The securities described above were offered in a private placement under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Act") and Regulation D promulgated thereunder and, along with the shares of common stock underlying the warrants sold in the offering, have not been registered under the Act or applicable state securities laws. Accordingly, such securities may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. Pursuant to a registration rights agreement, the Company has agreed to file one or more registration statements with the SEC covering the resale of the unregistered securities to be issued in the offering (the "Resale Registration Statement"). This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About SOBRsafe™ Through next-generation alcohol detection technology, we enable trust and empower recovery ... with a human touch. SOBRsafe's advanced transdermal (touch-based) technology detects and reports in real-time the presence of alcohol as emitted through a user's skin - no breath, blood, or urine samples are required. With a powerful backend data platform, SOBRsafe provides passive, dignified screening and monitoring solutions for the behavioral health, family law and consumer markets, and for licensing and integration. To learn more, visit www.sobrsafe.com. Safe Harbor Statement Our prospects here at SOBRsafe are subject to uncertainties and risks. This news release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934, including statements regarding the completion of the offering, the satisfaction of customary closing conditions related to the offering and the intended use of net proceeds from the offering, and the Compa

The holidays are a time of celebration and togetherness and navigating them alcohol-free can come with unique challenges. Between parties, happy hours, and long-standing family traditions that revolve around drinking, staying alcohol-free this time of year can feel extra challenging.More

If you’re wondering whether your drinking has become harmful, here are ten signs that it may be time to seek support.More